Peter B. Kang MD, FAAN, FAAP


Dr. Kang is a pediatric neurologist and physician-scientist whose clinical and research interests focus on neuromuscular disorders.  He has been Chief of the Division of Pediatric Neurology at the University of Florida since 2013 and Director of the Pediatric Neurology Residency Program since 2016.

Dr. Kang’s research laboratory focuses on the genetics of limb girdle muscular dystrophy and other pediatric neuromuscular disorders, along with the mechanisms of rare muscle diseases including MEGF10 myopathy, and he has published extensively on these subjects.  His work has been supported by the National Institutes of Health and the Muscular Dystrophy Association.  Among his former trainees, several are faculty members in the United States, Canada, South Korea, and Japan.

Dr. Kang is an associate editor of Muscle & Nerve and an editorial board member of two other journals: Neurologyand Pediatric Neurology.  He recently completed two terms on the editorial board of Pediatrics.  He is a member and former chair of the executive committee of the Section on Neurology of the American Academy of Pediatrics.  He has served on the Board of Directors of the Child Neurology Society, on the Ethics, Law and Humanities Committee of the American Academy of Neurology, and as Secretary-Treasurer of the Massachusetts Medical Society.  He completed medical school at the University of Pennsylvania, pediatric residency at Yale-New Haven Hospital, a pediatric neurology residency at the University of Pennsylvania, and a fellowship in clinical neurophysiology at Beth Israel Deaconess Medical Center.  Prior to his arrival at the University of Florida, Dr. Kang was an Associate Professor of Neurology at Harvard Medical School and the Director of the Electromyography Laboratory at Boston Children’s Hospital.


Amy L. Marini RN, BSN, CHTP

Amy has been a registered nurse focused on pediatric nursing for over 18 years.  Her passion to help children has been lifelong.  Her clinical experience started with staff nursing then transitioned to the role of clinical education specialist at the largest pediatric rehabilitation facility in the country for 13 years.  This coupled with ongoing private duty in home pediatric nursing has prepared her for the most important nursing role yet:  mom of three, two of whom have Cockayne Syndrome.  Since the diagnosis of her children in 2015 she has focused on creating awareness for Cockayne Syndrome and strives to help other families understand the complexities of the diagnosis so they can in turn advocate and help their children as much as possible.

Amy has her Bachelors in Nursing from William Paterson University and is also a Certified Healing Touch Practitioner.


Andrew E. Mulberg MD, FAAP, CPI


Andrew is currently the Head, Senior Vice President, Global Regulatory Affairs of Amicus Therapeutics, Inc. which focuses on rare disease drug development. He is the former Division Deputy Director of Gastroenterology and Inborn Errors Products, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA) since 2010.

Before joining FDA, Andrew has served as Portfolio Leader in Established Products responsible for providing worldwide leadership in support of GI and diverse Internal Medicine products within the Established Products Therapeutic Area of Johnson and Johnson from 2000-2010.  He has served as Attending Physician in Gastroenterology and Hepatology at Children’s Hospital of Philadelphia from 1993-2010.

Andrew is a graduate of Columbia College of Columbia University and of the Mount Sinai School of Medicine.  He completed his residency in Pediatrics at the Children’s Hospital of Philadelphia followed by a Pediatric Gastroenterology Clinical Fellowship and a Post-Doctoral Fellowship in Cellular and Molecular Physiology at New England Medical Center.  Andrew is Adjunct Professor of Pediatrics at the University of Maryland School of Medicine ,Adjunct Associate Professor of Pediatrics in the University of Pennsylvania School of Medicine and Associate Professor of Pharmacy at the University of the Sciences in Philadelphia.

He has served as Principal Editor of Pediatric Drug Development: Concepts and Applicationspublished April 2009 with Wiley-Blackwell and now in its 2nd edition released August 19, 2013.  He is a member of multiple professional medical societies including Alpha Omega Alpha Honor Medical Society, American Gastroenterological Association and the North American Society for Pediatric Gastroenterology and Nutrition.


Christina A. Pacak Ph.D.


Christina A. Pacak, PhD. is a translational molecular biologist with a long-standing personal interest in Cockayne syndrome. She has built a laboratory program to develop gene therapies for several forms of Cockayne syndrome and to gain a greater understanding of the underlying disease mechanisms.

Dr. Pacak is currently an Assistant Professor in the Department of Pediatrics at the University of Florida College of Medicine. She has served on national committees for the American Society of Gene and Cell Therapy and has published over a dozen peer-reviewed manuscripts describing the development or use of adeno-associated virus (AAV) as a gene delivery system to treat rare diseases.

Dr. Pacak earned her PhD at the University of Florida and completed a postdoctoral fellowship at Boston Children’s Hospital – Harvard Medical School.



Please click here to make a donation to the
National Initiative for Cockayne Syndrome

Thank you for your generosity

National Initiative for Cockayne Syndrome, incorporated in the State of Maryland, is a not-for-profit charity under section 501(c)(3) of the Internal Revenue Code and has full tax exempt status. Maryland Sales and Use Tax Exemption Number 31208646.

Contact us at